BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18432283)

  • 21. Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats.
    Sandström R; Lennernäs H
    Drug Metab Dispos; 1999 Aug; 27(8):951-5. PubMed ID: 10421625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pioglitazone on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rats.
    Choi JS; Burm JP
    Arch Pharm Res; 2008 Sep; 31(9):1200-4. PubMed ID: 18806964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verapamil metabolite exposure in older and younger men during steady-state oral verapamil administration.
    Abernethy DR; Wainer IW; Anacleto AI
    Drug Metab Dispos; 2000 Jul; 28(7):760-5. PubMed ID: 10859149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat.
    Laethem ME; Belpaire FM; Wijnant P; Rosseel MT; Bogaert MG
    Chirality; 1994; 6(5):405-10. PubMed ID: 8068500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol enantiomers in rat plasma by high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics.
    Godoy AL; De Moraes NV; Martinez EZ; Carvalho TM; Marques MP; Lanchote VL
    Chirality; 2011 Apr; 23(4):287-93. PubMed ID: 21384434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of verapamil and norverapamil in the eye and systemic circulation after topical administration of verapamil in rabbits.
    Siegner SW; Giovanoni RL; Erickson KA; Netland PA
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):159-68. PubMed ID: 9572542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of gasoline inhalation on the enantioselective pharmacokinetics of fluoxetine in rats.
    Cardoso JL; Lanchote VL; Pereira MP; Capela JM; Lepera JS
    Chirality; 2013 Mar; 25(3):206-10. PubMed ID: 23362155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction.
    Ling S; Jamali F
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):24-9. PubMed ID: 19371259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits.
    Choi JS; Han HK
    J Pharm Pharmacol; 2004 Dec; 56(12):1537-42. PubMed ID: 15563760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
    Choi DH; Chang KS; Hong SP; Choi JS; Han HK
    Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing.
    Johnson LM; Lankford SM; Bai SA
    J Vet Pharmacol Ther; 1995 Apr; 18(2):117-23. PubMed ID: 7629925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of verapamil on the pharmacokinetics of aliskiren in healthy participants.
    Rebello S; Leon S; Hariry S; Dahlke M; Jarugula V
    J Clin Pharmacol; 2011 Feb; 51(2):218-28. PubMed ID: 20413453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil in rabbits.
    Mori Y; Hanada K; Mori T; Tsukahara Y; Hashiguchi M; Ogata H
    Biol Pharm Bull; 2001 Jul; 24(7):806-10. PubMed ID: 11456122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chiral separation of verapamil and some of its metabolites by HPLC and CE.
    Brandsteterová E; Endresz G; Blaschke G
    Pharmazie; 2001 Jul; 56(7):536-41. PubMed ID: 11487971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: Application to pharmacokinetics.
    Lima RM; Ferreira MA; Ponte TM; Marques MP; Takayanagui OM; Garcia HH; Coelho EB; Bonato PS; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3083-8. PubMed ID: 19665946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.
    Hu N; Xie S; Liu L; Wang X; Pan X; Chen G; Zhang L; Liu H; Liu X; Liu X; Xie L; Wang G
    Drug Metab Dispos; 2011 Mar; 39(3):419-25. PubMed ID: 21135265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407.
    Lee YS; Yoon JN; Yoon IS; Lee MG; Kang HE
    Xenobiotica; 2012 Aug; 42(8):766-74. PubMed ID: 22300394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil: species differences and influence of endotoxin.
    Laethem ME; Belpaire FM; Wijnant P; Bogaert MG
    Chirality; 1995; 7(8):616-22. PubMed ID: 8593255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action.
    Mikus G; Eichelbaum M; Fischer C; Gumulka S; Klotz U; Kroemer HK
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1042-8. PubMed ID: 2359015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum concentration and antihypertensive effect of slow-release verapamil.
    Schütz E; Ha HR; Bühler FR; Follath F
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S346-9. PubMed ID: 6184566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.